BETA-NERVE GROWTH FACTOR, HUMAN structure
|
Common Name | BETA-NERVE GROWTH FACTOR, HUMAN | ||
---|---|---|---|---|
CAS Number | 86923-98-0 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Name | BETA-NERVE GROWTH FACTOR, HUMAN |
---|
Appearance of Characters | lyophilized powder |
---|---|
Storage condition | −20°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Effects of nerve growth factor antagonist K252a on peritoneal mast cell degranulation: implications for rat postoperative ileus.
Am. J. Physiol. Gastrointest. Liver Physiol. 309 , G801-6, (2015) Stabilization of mast cell (MC) degranulation has been proposed to prevent postoperative ileus (POI). Nerve growth factor (NGF) mediates MC degranulation. The aim of the study was to evaluate whether ... |
|
The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.
PLoS ONE 10(1) , e0116459, (2015) Depressive symptoms during pregnancy are common and may have impact on the developing child. Selective serotonin reuptake inhibitors (SSRIs) are the most prescribed antidepressant treatment, but unfor... |
|
Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
BMC Biol. 6 , 8, (2008) The transmissible spongiform encephalopathies (TSEs), otherwise known as the prion diseases, occur following the conversion of the normal cellular prion protein (PrPC) to an alternatively folded isofo... |